Regulated manufacturing
Pharmaceutical and biotechnology
Supply performance depends on a controlled passage from demand and materials through manufacture, evidence, disposition and release.
Representative operating architecture
Flow progresses from left to right
| Architecture | Balance supply | Control materials | Manufacture | Test | Disposition | Release |
|---|---|---|---|---|---|---|
| Operating flow | Translate demand into feasible supply | Establish identity, availability and status | Execute the approved process | Generate and review analytical evidence | Resolve exceptions and determine status | Authorize supply for market use |
| Decisions and controls | Supply commitment | Material-status authority | Recipe, resource and exception control | Method and result acceptance | Quality disposition | Release authorization |
| Information foundation | Demand, order and capacity | Material, lot, identity and status | Recipe, batch, equipment and resource | Sample, method, specification and result | Deviation, investigation and evidence | Released inventory and shipment status |
| Technology estate | ERP and planning platforms | ERP and warehouse systems | MES and process automation | LIMS and laboratory platforms | QMS and controlled content | ERP and distribution platforms |
Critical continuity: material identity, batch evidence and quality status. Highlighted controls indicate recurrent operating pressure.